Search for: "Brooks v. Abbott" Results 1 - 20 of 69
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Nov 2010, 6:06 am by Amanda Rice
At SCOTUSblog, Brooks Holland analyzes the Court’s unanimous opinion in Abbott v. [read post]
10 Nov 2011, 1:42 am by NL
This statement was referred to with approval by Sir Edward Coke in Co Litt 42a (1628), and much the same is stated in Brook’s New Cases (1554/5) pl 462. [read post]
10 Nov 2011, 1:42 am by NL
This statement was referred to with approval by Sir Edward Coke in Co Litt 42a (1628), and much the same is stated in Brook’s New Cases (1554/5) pl 462. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas)… [read post]
9 Aug 2010, 12:58 am by Kelly
Brooks Brothers oral argument (Gray on Claims) Therasense – Abbott files brief in Therasense case: Therasense Inc. v. [read post]
17 Mar 2011, 12:31 am
" Brooks Furniture Mfg., Inc. v. [read post]
26 Aug 2021, 9:03 pm by Jillian Moss
Virginia State Board of Elections and Cooper v. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description:… [read post]
10 Jan 2018, 2:17 pm by John Elwood
Perez, 17-586, and Abbott v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]